SOPHiA GENETICS (SOPH) CFO lists shares, options and RSUs in Form 3
Rhea-AI Filing Summary
SOPHiA GENETICS SA Chief Financial Officer George Cardoza filed an initial ownership report showing his equity position in the company. He holds 185,632 Ordinary Shares directly. He also holds share options over 183,333 Ordinary Shares at an exercise price of $3.4000 per share, expiring on December 18, 2034, and separate share options over 187,500 Ordinary Shares at an exercise price of $3.2900 per share, expiring on April 2, 2035. Footnotes state that 70,826 additional Ordinary Shares are issuable upon settlement of restricted stock units, vesting over time subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
CARDOZA GEORGE
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 370,833 shares (Direct);
Ordinary Shares — 185,632 shares (Direct)
Footnotes (3)
- F1. Includes 70,826 ordinary shares issuable upon settlement of two restricted stock unit ("RSU") grants. Each RSU represents a contingent right to receive one ordinary share of the Issuer, vesting subject to the Reporting Person's continued service with the Issuer, as follows: (i) 28,388 ordinary shares from a December 18, 2024 grant vesting in equal quarterly installments through December 18, 2028; and (ii) 42,438 ordinary shares from an April 2, 2025 grant, with 50% vesting on April 2, 2026 and the remainder vesting in equal quarterly installments through April 2, 2027.
- F2. The share option vests and becomes exercisable as to 25% of the ordinary shares on December 18, 2025, and then in equal monthly installments through December 18, 2028.
- F3. The share option vests and becomes exercisable as to 50% of the ordinary shares on April 2, 2026, and then in equal monthly installments through April 2, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does George Cardoza’s Form 3 for SOPHiA GENETICS SA (SOPH) show?
The Form 3 reports George Cardoza’s initial ownership in SOPHiA GENETICS SA as Chief Financial Officer. It discloses his directly held Ordinary Shares, outstanding share options over additional Ordinary Shares, and restricted stock units that may convert into shares as vesting conditions are met.